SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000892569-05-000916
Filing Date
2005-10-18
Accepted
2005-10-17 21:57:44
Documents
4
Period of Report
2005-12-02

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT a13487ppre14a.htm PRE 14A 1432428
2 GRAPHIC a13487pa1348700.gif GRAPHIC 825
3 GRAPHIC a13487pa1348701.gif GRAPHIC 2077
4 GRAPHIC a13487pa1348702.gif GRAPHIC 9242
  Complete submission text file 0000892569-05-000916.txt   1451034
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-24274 | Film No.: 051141945
SIC: 2836 Biological Products, (No Diagnostic Substances)